摘要
目的:观察醒脑静对脑复苏后S-100β蛋白水平的变化影响及预后的研究。方法:选取非神经源性心脏骤停患者为观察对象,随机分为正常对照组、常规治疗对照组和醒脑静治疗组,在自主循环恢复后半小时、2、12h取血标本,采用ELISA的方法测定血清S-100β蛋白的水平。结果:与正常对照组相比,脑复苏常规组患者血清S-100β蛋白的含量均明显增高,P<0.05,醒脑静治疗组各时间点患者血清S-100β蛋白的含量比较,差异无统计学意义,P>0.05;与脑复苏常规组相比,醒脑静治疗组各时间点患者血清S-100β蛋白的含量均明显降低,P<0.05。结论:醒脑静能够明显改善脑复苏后S-100β蛋白水平及预后。
Objective： To discuss a blood serum S-100 bet protein levels change and prognosis relations after Xingnaojing resuscitation. Methods： All patients were randomly assigned to common treatment group, receive Xingnaojing group and control group. We obtained serum S-100β protein of the patients at admission time. Results： The S-100β serum value after stroke in common treatment group was higher than that of the control group. The S-100β serum value after stroke in Xingnaojin group was lower than the common treatment group. Conclusion： Xingnaojing can improve neurological function and decrease S-100β serum concentration.
出处
《中国当代医药》
2010年第14期30-31,共2页
China Modern Medicine
基金
广东省广州市卫生局科研课题(项目编号:2007B55)
